Pharma’s Digital Pathology Build-Out; Part 1 – The State Of Play

 
• By Rachel Laing, Sophie Peltre, and Mark Ratner

Pharma companies are applying digital pathology throughout their research and development functions. Where are they now finding value?  

Build out
Pharma is building digital pathology capacity • Source: Shutterstock

More from Innovation

More from In Vivo